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In the recentCell Host and Microbe publication by Camarena et al., a number of errors in the text and the figure legends were missed
at the proofs stage. The errors listed belowwere not included in the print version but have since been corrected in the online version of
the original article.
Page 320. In the list of affiliations, the Department of Neural Science should be corrected to ‘‘Center for Neural Science.’’
Page 323. The sentence ‘‘This provides a basis for scoring the number of GFP-positive wells rather than individual cells’’ should be
moved to the end of the paragraph.
Page 325, 1st paragraph. The two citations to Figure 3D should be changed to Figure 3G.
Page 326, Discussion. A reference to (Figure 6A) should be placed at the end of the second paragraph of the Discussion.
Page 327, Right column. The top line should read ‘‘Our study shows that differences in the duration of PI3-K-mediated Akt activation
by RTK signaling directly correlate with the ability to maintain HSV-1 latency.’’
Figure 2 legend. The entire text for (A)’s legend should be switched with (B)’s legend.
Figure 3A legend. The references to ‘‘Shc, homologous, and collagen-like adaptor protein; Grb2, growth factor receptor bound
protein 2; Gab1, Grb2-associted binder-1’’ should be deleted from the figure legend, since they are not in the model presented in (A).
Figure 3E legend. The word ‘‘reactivated’’ should be inserted in the sentence, to read as so: ‘‘Number of reactivated GFP+ neurons
after 48 hr of treatment with LY294002 or vehicle DMSO in the presence of WAY-150138 (20 mg/ml).’’
Figure 5A legend. The entire sentence should be corrected to read as so: ‘‘GFP-HSV-1 latently infected SCG neuron cultures were
established in the presence of NGF and EGF (50 ng/ml each), washed and then cultured for 5 days in media containing NGF and EGF
(filled bar); anti-EGF and anti-NGF antibody (open bar); and EGF and anti-NGF antibody (shaded bar).’’
Figure 5B legend. The sentence ‘‘The error bars indicated the standard error of the mean’’ should be included at the end of (B)’s
legend and deleted from the legends of (C and D).
Figure 6B legend. The sentence ‘‘The error bars indicate the standard error of the mean’’ should be placed at end of (B)’s legend and
deleted from (E)’s legend.
Figure 6B legend. The two concentrations for AKT inhibitor VIII and LY294002 should be in mM, instead of in mM.
Experimental Procedures. Under the section ‘‘Cell Culture and HSV-1 Infection,’’ the concentration of ACV should be 50 mM, not mM.
The reference to Efstathiou and Preston (2005) should be removed here and in the References section. Also, under the section
‘‘Viability Assay by Hoechst Staining,’’ the verb should be corrected as so: ‘‘One week after plating, SCG cultures were treated
with anti-NGF blocking antibodies in the presence or absence of 20 mM ZVAD-fmk (627610, Calbiochem).’’
Any inconvenience and confusion caused by these errors and their subsequent correction in the online version is regretted.Cell Host & Microbe 8, 551, December 16, 2010 ª2010 Elsevier Inc. 551
